Invitations for screening appointments are usually issued every three years to individuals aged between 50 and 71 ...

Amy Dowden has opened up about her gruelling cancer battle a year after receiving the all-clear. The Strictly Come Dancing ...

Cost-effectiveness watchdog NICE has recommended routine NHS use of two new therapies for women with advanced breast cancer – Gilead's Trodelvy and Novartis' Piqray – in England.

despite Nice and NHS England offering unprecedented flexibilities in negotiations. “Enhertu is the first breast cancer treatment that Nice has been unable to recommend in over six years ...

which has been recommended for NHS use in England and Wales, and is funded from today in England. Linda is one of more than 1,000 women with incurable breast cancer who could benefit from the drug ...

A "huge breakthrough" in breast cancer ... quick approval of breast cancer drugs so they can be made available promptly to those who need them,” she said. “NHS England must now put in place ...

Claire Rowney, chief executive at Breast Cancer Now, said: “We’re delighted that NICE has recommended capivasertib with fulvestrant for use on the NHS in England, offering certain people ...

A BLOOD test that can detect cancer before symptoms develop will be offered as part of an NHS trial, health officials have ...

A PILL which is taken twice a day for the most common type of advanced breast cancer has been approved on the NHS in what scientists say is a "landmark moment". Up to 3,000 women every year could ...